These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4238678)

  • 1. [Clinical controlled experimentation of a combination of a peripheral vasodilator agent and a clarifying and hypolipemic agent].
    Nicrosini F; Butti A; Pasotti C
    Farmaco Prat; 1969 Mar; 24(3):157-66. PubMed ID: 4238678
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypocholesterolemic activity of the combination of ethyl-p-chlorophenoxyisobutyrate and extractive sulfomucopolysaccharide].
    Nicrosini F; Butti A; Pasotti C
    Farmaco Prat; 1968 May; 23(5):256-62. PubMed ID: 4238576
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypolipemic effect of an association of an extractive mucopolysaccharide and the ethyl ester of the p-chlorophenoxyisobutyric acid].
    Coscelli C; Palmari V; Gnudi A
    Farmaco Prat; 1968 Sep; 23(9):482-90. PubMed ID: 4238440
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experimentation on the tolerance and efficacy of Lamuran administered by phleboclysis in 39 patients with peripheral vascular diseases].
    Dotti GC
    Minerva Med; 1973 May; 64(34):1821-30. PubMed ID: 4719379
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age].
    Andalò L; Missana M
    Clin Ter; 1975 Sep; 74(5):471-84. PubMed ID: 819202
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of the therapeutic activity of the beta-pyridyl-carbinolic ester of clofibric acid].
    Silingardi V; Renzi R; Mora A; Di Prisco AU
    Minerva Med; 1973 Mar; 64(16):751-69. PubMed ID: 4579325
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinical study of a spasmolytic agent (cyclospasmol) in the treatment of elderly arteriosclerotic patients.
    Ward PJ
    Ulster Med J; 1965 Dec; 34(2):129-36. PubMed ID: 5326929
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study].
    Lefebvre P; Crocq L; Bernard JG
    Sem Hop; 1969 Jan; 45(5):312-7. PubMed ID: 4307724
    [No Abstract]   [Full Text] [Related]  

  • 9. Perhexiline maleate in angina pectoris. A controlled, double-blind clinical trial.
    Bleifer DJ; Bleifer SB; Okun R
    Geriatrics; 1972 Sep; 27(9):109-15. PubMed ID: 4626492
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of the new coronary dilator hexobendine].
    Henke C; Dudik E; Steim H
    Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the treatment of peripheral arterial circulatory disorders].
    Heide M
    Hippokrates; 1969 May; 40(9):354-7. PubMed ID: 5800170
    [No Abstract]   [Full Text] [Related]  

  • 12. [Angina pectoris by effort. Effect of Bay a 1040].
    Arce Gómez E; Aspe y Rosas J; Alcocer Diaz L
    Prensa Med Mex; 1976; 41(1-2):56-62. PubMed ID: 778824
    [No Abstract]   [Full Text] [Related]  

  • 13. Perhexiline maleate in the treatment of angina pectoris.
    Hirshleifer I
    Curr Ther Res Clin Exp; 1969 Mar; 11(3):99-105. PubMed ID: 4975919
    [No Abstract]   [Full Text] [Related]  

  • 14. [A double-blind controlled clinical study on the use of mucopolysaccharides in the treatment of patients with cerebral vasculopathy. Comparison with a placebo].
    Bardin P; Campo R
    Clin Ter; 1987 Jan; 120(2):111-8. PubMed ID: 2972439
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative double-blind study on the normolipemic effect of clofibrate and a clofibrate-mucopolysaccharide extract combination].
    Cagli V; Lillo V
    Clin Ter; 1975 Oct; 75(2):153-69. PubMed ID: 132333
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
    Coscia M
    Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences with the use of carbochromen in coronary syndrome].
    Ivancić R; Persić T; Custović F
    Arzneimittelforschung; 1970 Mar; 20():454-6. PubMed ID: 4916580
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of essential hypertension with trimazosin, a new vasodilator agent.
    Vlachakis ND; Mendlowitz M; De Guzman de Guzman D
    Curr Ther Res Clin Exp; 1975 Jun; 17(6):564-9. PubMed ID: 808379
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of severe arterial hypertension with propyldazine (ISF 2123) associated with a diuretic and a beta-blocking agent].
    Angelino PF; Lavezzaro G; Carnovali M
    Minerva Cardioangiol; 1979 Mar; 27(3):113-8. PubMed ID: 37462
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.
    Crepaldi G; Fellin R; Calabrò A; Baiocchi MR; Rossi A; Lenzi S; Descovich GC; Delmonte G; Gaddi A; Ventura A
    Monogr Atheroscler; 1986; 14():215-21. PubMed ID: 3526129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.